Portfolio company
Strand Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops programmable messenger RNA therapies for patients with solid tumours and autoimmune diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Strand Tx
Strand Tx develops programmable messenger RNA therapeutics for patients with cancer and autoimmune diseases.
Synthetic biology-powered mRNA therapeutics
The company develops programmable mRNA therapies using synthetic biology genetic circuits to deliver precise treatments for patients with cancer and other complex diseases.
ArsenalBio
The company develops programmable T cell therapies for patients with solid tumours and autoimmune diseases.
Typewriter Therapeutics
The company develops RNA-based genetic medicines for patients with cancer, autoimmune conditions and rare genetic diseases.
Nykode Therapeutics
This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.
Orna Therapeutics
This company develops engineered circular RNA therapies and delivery systems to treat patients with cancer, autoimmune conditions, and genetic diseases.
Outpace Bio
This biotechnology company develops custom protein-designed cell therapies to treat solid tumours and autoimmune diseases for patients and pharmaceutical partners.
Flamingo Therapeutics
This biotechnology company develops RNA-targeted therapies to treat various forms of cancer for patients with solid tumours.